Study name |
The Effect of S‐ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) (ECT) |
Methods |
RCT |
Participants |
American Society of Anesthesiologists (ASA) Physical Status I‐II
diagnose depressive disorders with DSM‐IV
Without cognitive impairment
Without ECT in past 6 months
|
Interventions |
Placebo Comparator: Propofol group patients were treated with propofol 1 mg/kg and saline bolus infusion before ECT Active Comparator: Ketamine group patients were treated with propofol 1 mg/kg and ketamine 0.5 mg/kg bolus infusion before ECT Experimental: S‐ketamine group patients were treated with propofol 1 mg/kg and S‐ketamine 0.25 mg/kg bolus infusion before ECT |
Outcomes |
Hamilton Depression Scale‐17 scores [ Time Frame: the 1 day after the last ECT ]the patients' depression were evaluated with Hamilton Depression Scale with 17 questions after ECT. The scores ranged 0‐68, and <7 were normal, the higher the score means more serious disease.
Montgomery‐Asberg Depression Rating Scale scores [ Time Frame: the 1 day after the last ECT ]the patients' depression were evaluated with Montgomery‐Asberg Depression Rating Scale scores after ECT. The scores ranged 0‐60, and <17 were normal, the higher the score means more serious disease.
|
Starting date |
August 1, 2020 |
Contact information |
qiuyan_mz@126.com |
Notes |
NCT04399070 |